147 related articles for article (PubMed ID: 37675621)
21. Label-Free Quantitative Proteomics Identifies Novel Biomarkers for Distinguishing Tuberculosis Pleural Effusion from Malignant Pleural Effusion.
Pan L; Zhang X; Jia H; Huang M; Liu F; Wang J; Du B; Wei R; Sun Q; Xing A; Li Q; Zhang Z
Proteomics Clin Appl; 2020 Jan; 14(1):e1900001. PubMed ID: 31715074
[TBL] [Abstract][Full Text] [Related]
22. Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC).
Lin XJ; Li QJ; Lao XM; Yang H; Li SP
BMC Cancer; 2015 Oct; 15():707. PubMed ID: 26470869
[TBL] [Abstract][Full Text] [Related]
23. Variations in pleural microbiota and metabolic phenotype associated with malignant pleural effusion in human lung adenocarcinoma.
Huang D; Zhuo J; Ye C; Su X; Chen Y; Li C; Lin L; Liu L; Zhao H; Luo T; Ren Q; Wu J; Cai S; Dong H
Thorac Cancer; 2023 Jul; 14(21):2045-2056. PubMed ID: 37309281
[TBL] [Abstract][Full Text] [Related]
24. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
25. Clinical importance of serum and pleural fluid prominin-1 and hypoxia-inducible factor-1α concentration in the evaluation of lymph node involvement in patients with malignant pleural effusion.
Ozmen ZC; Kupeli M
Biochem Med (Zagreb); 2023 Oct; 33(3):030701. PubMed ID: 37841777
[TBL] [Abstract][Full Text] [Related]
26. Novel therapies for malignant pleural effusion: Anti‑angiogenic therapy and immunotherapy (Review).
He D; Ding R; Wen Q; Chen L
Int J Oncol; 2021 Mar; 58(3):359-370. PubMed ID: 33650668
[TBL] [Abstract][Full Text] [Related]
27. Microbiome profile associated with malignant pleural effusion.
Shojaee S; Sharma A; Gottel N; Sanchez T; Gilbert JA; Rahman NM
PLoS One; 2020; 15(5):e0232181. PubMed ID: 32384089
[TBL] [Abstract][Full Text] [Related]
28. [Therapeutical effects of pleural injecting recombinant human endostain to
malignant pleural effusion nude mice model].
Zhou M; Li M; Yang H; Hu C
Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):266-71. PubMed ID: 25975296
[TBL] [Abstract][Full Text] [Related]
29. The intrapleural administration with thymic peptides in malignant pleural effusion: A clusteredsystematicreview and meta-analysis.
Wang CQ; Shen YS; Chen XF; Jiang H; Yang XM; Fan TY; Li SG; Yang P; Zhan L; Chen R; Feng JH; Xiao X; Xiao Z
Int Immunopharmacol; 2022 Jun; 107():108688. PubMed ID: 35293322
[TBL] [Abstract][Full Text] [Related]
30. Effective Treatment for Malignant Pleural Effusion and Ascites with Combined Therapy of Bevacizumab and Cisplatin.
Jiang L; Li P; Gong Z; Hu B; Ma J; Wang J; Chu H; Zhang L; Sun P; Chen J
Anticancer Res; 2016 Mar; 36(3):1313-8. PubMed ID: 26977031
[TBL] [Abstract][Full Text] [Related]
31. Next-generation sequencing reveals mutational accordance between cell-free DNA from plasma, malignant pleural effusion and ascites and directs targeted therapy in a gastric cancer patient.
Zhou S; Xu B; Qi L; Zhu D; Liu B; Wei J
Cancer Biol Ther; 2019; 20(1):15-20. PubMed ID: 30118648
[TBL] [Abstract][Full Text] [Related]
32. [Impact of intrapleural hyperthermic perfusion on immunologic reaction state of cytokines TH1/TH2 of lung carcinoma patients with malignant pleural effusion].
Kang MQ; Cao YP; Deng F
Ai Zheng; 2008 Feb; 27(2):210-3. PubMed ID: 18279624
[TBL] [Abstract][Full Text] [Related]
33. Recombinant Human Adenovirus Type 5 (H101) Intra-Tumor Therapy in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer: Genomic Profiling Relating to Clinical Efficacy.
Zhang Q; Zhang J; Liu Z; Wang J; Wang F; Wang T; Shi F; Su J; Zhao Y
Drug Des Devel Ther; 2023; 17():3507-3522. PubMed ID: 38046281
[TBL] [Abstract][Full Text] [Related]
34. Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: a pilot phase II clinical trial.
Lu W; Zheng S; Li XF; Huang JJ; Zheng X; Li Z
World J Gastroenterol; 2004 Dec; 10(24):3634-8. PubMed ID: 15534920
[TBL] [Abstract][Full Text] [Related]
35. Predicting malignant pleural effusion during diagnostic pleuroscopy with biopsy: A prospective multicentre study.
Grosu HB; Kern R; Maldonado F; Casal R; Andersen CR; Li L; Eapen G; Ost D; Jimenez C; Frangopoulos F; Sabath B; Vakil E; Schwalk A; Marcoux M; Sagar AE; Nasim F; Lin J; Salahudin M; Arain HM; Noor L; Montanez D; Stewart J; Mullon J; Michael M; Porfyridis I
Respirology; 2022 May; 27(5):350-356. PubMed ID: 35178828
[TBL] [Abstract][Full Text] [Related]
36. High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion.
Yi F; Zhang X
Medicine (Baltimore); 2019 Sep; 98(38):e17253. PubMed ID: 31567996
[TBL] [Abstract][Full Text] [Related]
37. Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.
Tamiya M; Tamiya A; Yasue T; Nakao K; Omachi N; Shiroyama T; Tani E; Hamaguchi M; Morishita N; Suzuki H; Okamoto N; Okishio K; Kawaguchi T; Atagi S; Hirashima T
Anticancer Res; 2016 Jun; 36(6):2939-44. PubMed ID: 27272808
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients.
Zhang Z; Ji W; Huang J; Zhang Y; Zhou Y; Zhang J; Dong Y; Yuan T; Yang Q; Ding X; Tang L; Li H; Yin J; Wang Y; Ji T; Fei J; Zhang B; Chen P; Hu H
Clin Transl Med; 2022 Nov; 12(11):e1072. PubMed ID: 36305631
[TBL] [Abstract][Full Text] [Related]
39. Advanced malignant pleural or peritoneal effusion in patients treated with recombinant adenovirus p53 injection plus cisplatin.
Dong M; Li X; Hong LJ; Xie R; Zhao HL; Li K; Wang HH; Shin WD; Shen HJ
J Int Med Res; 2008; 36(6):1273-8. PubMed ID: 19094436
[TBL] [Abstract][Full Text] [Related]
40. Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis.
Lombardi G; Nicoletto MO; Gusella M; Fiduccia P; Dalla Palma M; Zuin A; Fiore D; Donach M; Zagonel V
Cancer Chemother Pharmacol; 2012 Mar; 69(3):781-7. PubMed ID: 22037881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
